Skip to main content
. 2022 Jun 1;50(Suppl):77–138.

Table 3.

Nicotine replacement therapy: dosage guidelines, safety and other clinical considerations

NICOTINE Patches Chewing gum Tablets Oral spray
Format 24-hr release:
7, 14 and 21 mg
16-hr release:
10 and 15 mg
2 and 4 mg 1, 2, 1.5 and 4 mg 1 mg
Dosage > 10 cig/day:
21 mg/day (4–6 weeks)
14 mg/day (2 weeks)
7 mg/day (2 weeks)
≤ 10 cig/day:
14 mg/day (6 weeks)
7 mg/day (2 weeks)
1st cig ≤ 30 min after getting up: 4 mg
1st cig > 30 min after getting up: 2 mg
1-6 weeks: 1/1-2 h
7-9 weeks: 1/2-4 h
10–12 weeks: 1/4-8 h
1st cig ≤ 30 min after getting up: 2 mg
1st cig > 30 min after getting up: 1 mg
1-6 weeks: 1/ 1-2 h
7-9 weeks: 1/2-4 h
10–12 weeks: 1/4-8 h
1-2 sprays in the mouth (6 weeks) if you feel like smoking; reduce progressively afterwards
Precautions Recent myocardial infarction (≤ 2 weeks); serious arrhythmias; angina pectoris; pregnancy and lactation; adolescents (< 18 years)
Temporomandibular dysfunction (with gum) and bronchospasm (with spray)
Most common side effects Local skin reaction (pruritus, heat, erythema)
Sleep disorders associated with nicotine absorption at night (insomnia, vivid dreams)
Oral and pharyngeal irritation
Inconvenience
Gastrointestinal discomfort (dyspepsia, nausea)
Hiccup
Jaw muscle pain
Oral and pharyngeal irritation.
Gastrointestinal discomfort (dyspepsia, nausea)
Hiccup
Advantages High adherence
Can be combined with other therapeutic drugs
24-hour release
Possibility of oral replacement therapy
Lower weight gain
Individual dosing to control withdrawal and other symptoms
Can be combined with other drugs for TUD
Disadvantages No adjustments allowed in monotherapy.
Not suitable for patients with dermatological disorders
Requires adequate dose control
Not suitable for patients undergoing dental treatment
Requires training in the form of use to achieve adequate effectiveness
Requires adequate dose control